Trade Report: The Team Health Holdings’ (TMH) “Buy” Rating Reiterated at Leerink Swann

The Team Health Holdings’ (TMH) “Buy” Rating Reiterated at Leerink Swann

Leerink Swann reaffirmed their buy rating on shares of Team Health Holdings Inc. (NYSE:TMH) in a report issued on Wednesday morning.

TMH has been the topic of a number of other research reports. Zacks Investment Research lowered shares of Team Health Holdings from a hold rating to a sell rating in a research report on Tuesday, July 19th. Jefferies Group set a $47.00 target price on shares of Team Health Holdings and gave the stock a buy rating in a research report on Wednesday, September 7th. Bank of America Corp. restated a buy rating and set a $52.00 target price on shares of Team Health Holdings in a research report on Tuesday, June 21st. Barclays PLC restated a buy rating on shares of Team Health Holdings in a research report on Sunday, July 10th. Finally, SunTrust Banks Inc. decreased their target price on shares of Team Health Holdings from $54.00 to $50.00 and set a buy rating on the stock in a research report on Thursday, August 4th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and eleven have assigned a buy rating to the company’s stock. Team Health Holdings currently has a consensus rating of Buy and an average price target of $47.27.

Team Health Holdings (NYSE:TMH) opened at 38.38 on Wednesday. Team Health Holdings has a 1-year low of $30.83 and a 1-year high of $63.56. The firm has a market cap of $2.85 billion, a P/E ratio of 63.54 and a beta of 1.18. The firm has a 50 day moving average of $33.94 and a 200 day moving average of $40.23.

Team Health Holdings (NYSE:TMH) last announced its earnings results on Tuesday, August 2nd. The company reported $0.66 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.65 by $0.01. Team Health Holdings had a net margin of 0.74% and a return on equity of 29.71%. The firm had revenue of $1.12 billion for the quarter, compared to analyst estimates of $1.17 billion. During the same quarter last year, the business earned $0.70 earnings per share. Team Health Holdings’s revenue was up 27.9% compared to the same quarter last year. On average, equities research analysts expect that Team Health Holdings will post $2.68 EPS for the current year.

Large investors have recently added to or reduced their stakes in the stock. Jana Partners LLC bought a new position in shares of Team Health Holdings during the first quarter valued at $246,276,000. Pennant Capital Management LLC raised its position in shares of Team Health Holdings by 1.2% in the first quarter. Pennant Capital Management LLC now owns 2,940,943 shares of the company’s stock valued at $122,961,000 after buying an additional 35,000 shares in the last quarter. GW&K Investment Management LLC raised its position in shares of Team Health Holdings by 1.0% in the second quarter. GW&K Investment Management LLC now owns 876,479 shares of the company’s stock valued at $35,646,000 after buying an additional 8,842 shares in the last quarter. BlackRock Group LTD raised its position in shares of Team Health Holdings by 2.3% in the first quarter. BlackRock Group LTD now owns 80,806 shares of the company’s stock valued at $3,378,000 after buying an additional 1,849 shares in the last quarter. Finally, Geode Capital Management LLC raised its position in shares of Team Health Holdings by 5.6% in the first quarter. Geode Capital Management LLC now owns 517,776 shares of the company’s stock valued at $21,648,000 after buying an additional 27,443 shares in the last quarter.

About Team Health Holdings

Related posts

Leave a Comment